| 2301 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2302 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2303 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2304 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2305 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2306 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2307 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2308 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2309 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2310 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2311 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
39 |
| 2312 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2313 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2314 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2315 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2316 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2317 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2318 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2319 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2320 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2321 |
Apheresis |
Autologous |
Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
37 |
| 2322 |
Apheresis |
Allogeneic |
Bare Lymphocyte Syndrome Type Ii |
Hematology |
2023 |
Standard Therapy |
Poland |
3 months |
| 2323 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2324 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2325 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2326 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2327 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
27 |
| 2328 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2329 |
Apheresis |
Allogeneic |
Beta Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2330 |
Apheresis |
Allogeneic |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2331 |
Apheresis |
Allogeneic |
Cell Neoplasm |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2332 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2333 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2334 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
36 |
| 2335 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2336 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2337 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2338 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2339 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2340 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2341 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2342 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
28 |
| 2343 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2344 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2345 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2346 |
Apheresis |
Autologous |
Composite Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
71 |
| 2347 |
Apheresis |
Allogeneic |
Congenital Pulmonary Lymphangiectasia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2348 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2349 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2350 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2351 |
Apheresis |
Allogeneic |
Ewing Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2352 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
62 |
| 2353 |
Apheresis |
Allogeneic |
Follicular Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2354 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2023 |
Standard Therapy |
Poland |
4 months |
| 2355 |
Apheresis |
Autologous |
Hodgkin – Relapse |
Hematology |
2023 |
Standard Therapy |
Germany |
43 |
| 2356 |
Apheresis |
Allogeneic |
Huntington's Disease (Hd) |
Hematology |
2023 |
Standard Therapy |
Germany |
36 |
| 2357 |
Apheresis |
Allogeneic |
Hypoplastic Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
27 |
| 2358 |
Apheresis |
Allogeneic |
Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2359 |
Apheresis |
Allogeneic |
Inherited Immune System Disorder |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2360 |
Apheresis |
Allogeneic |
Langerhans Cell Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2361 |
Apheresis |
Autologous |
Light-Chain Amyloidosis |
Hematology |
2023 |
Standard Therapy |
Germany |
62 |
| 2362 |
Apheresis |
Allogeneic |
Macrofocal Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
94 |
| 2363 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2364 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2365 |
Apheresis |
Allogeneic |
Mast Cell Sarcoma, Systemic Mastocytosis Nr |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2366 |
Apheresis |
Allogeneic |
Mixed Phenotype Acute Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2367 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2023 |
Standard Therapy |
Germany |
43 |
| 2368 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2023 |
Standard Therapy |
Germany |
57 |
| 2369 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2370 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2371 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
53 |
| 2372 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
65 |
| 2373 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2374 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2375 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2376 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
72 |
| 2377 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2378 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
68 |
| 2379 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2380 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
67 |
| 2381 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
69 |
| 2382 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2383 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2384 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2385 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2386 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2387 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
69 |
| 2388 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
58 |
| 2389 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
56 |
| 2390 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2391 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2392 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2393 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
53 |
| 2394 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2395 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2396 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2397 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2398 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2399 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
68 |
| 2400 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |